SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-020172
Filing Date
2021-08-16
Accepted
2021-08-16 16:16:21
Documents
50
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 901374
2 ex31-1.htm EX-31.1 18197
3 ex31-2.htm EX-31.2 18142
4 ex32-1.htm EX-32.1 8699
5 ex32-2.htm EX-32.2 8542
  Complete submission text file 0001493152-21-020172.txt   3710830

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ntec-20210630.xsd EX-101.SCH 40639
7 XBRL CALCULATION FILE ntec-20210630_cal.xml EX-101.CAL 39813
8 XBRL DEFINITION FILE ntec-20210630_def.xml EX-101.DEF 134184
9 XBRL LABEL FILE ntec-20210630_lab.xml EX-101.LAB 275080
10 XBRL PRESENTATION FILE ntec-20210630_pre.xml EX-101.PRE 202729
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 417984
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40652 | Film No.: 211178410
SIC: 2834 Pharmaceutical Preparations